Cited by 28Curcumin's Biomedical ApplicationsNatural Antidiabetic Agents StudiesGenomics, phytochemicals, and oxidative stress

Curcumin induces secretion of glucagon-like peptide-1 through an oxidation-dependent mechanism

Open access
Alli-Oluwafuyi, Abdul-Musawwir, Luis, Paula B., Nakashima, Fumie, Giménez-Bastida, Juan A., Presley, Sai Han, Duvernay, Matthew T., Iwalewa, Ezekiel O., Schneider, Claus·2019·Biochimie

Abstract

Curcumin shows antiglycemic effects in animals. Curcumin is chemically unstable at physiological pH, and its oxidative degradation products were shown to contribute to its anti-inflammatory effects. Since the degradation products may also contribute to other effects, we analyzed their role in the antiglycemic activity of curcumin. We quantified curcumin-induced release of glucagon-like peptide 1 (GLP-1) from mouse STC-1 cells that represent enteroendocrine L-cells as a major source of this anti-diabetic hormone. Curcumin induced secretion of GLP-1 in a dose-dependent manner. Two chemically stable analogues of curcumin that do not readily undergo degradation, were less active while two unstable analogues were active secretagogues. Chromatographically isolated spiroepoxide, an unstable oxidative metabolite of curcumin with anti-inflammatory activity, also induced secretion of GLP-1. Stable compounds like the final oxidative metabolite bicyclopentadione, and the major plasma metabolite, curcumin-glucuronide, were inactive. GLP-1 secretion induced by curcumin and its oxidative degradation products was associated with activation of PKC, ERK, and CaM kinase II. Since activity largely correlated with instability of curcumin and the analogues, we tested the extent of covalent binding to proteins in STC-1 cells and found it occurred with similar affinity as N-ethylmaleimide, indicating covalent binding occurred with nucleophilic cysteine residues. These results suggest that oxidative metabolites of curcumin are involved in the antiglycemic effects of curcumin. Our findings support the hypothesis that curcumin functions as a pro-drug requiring oxidative activation to reveal its bioactive metabolites that act by binding to target proteins thereby causing a change in function.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biochi.2019.08.013

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Alli-Oluwafuyi, A.-M., Luis, P. B., Nakashima, F., Giménez-Bastida, J. A., Presley, S. H., Duvernay, M. T., Iwalewa, E. O., & Schneider, C.
Affiliations
  • Vanderbilt University (US)
  • University of Ibadan (NG)
Corresponding author
Schneider, Claus
Venue
Biochimie
Publisher
Elsevier BV
Published
2019-10
Volume
165
Pages
250-257
ISSN
  • 0037-9042 (ISSN-L)
  • 0300-9084
OpenAlex
W2970063904
Cited by
28
References
53
Citations by year
2026: 6 · 2025: 6 · 2024: 5 · 2023: 2 · 2022: 2 · 2021: 5 · 2020: 1 · 2019: 1
FWCI
0.78
Type
journal article
Language
en
Open access
Locations
  • Biochimie (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (R01AT006896)
  • Fulbright Scholarship (E056609)
  • American Heart Association (16POST30690001)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Curcumin's Biomedical Applications
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
Keywords
curcumin, glucagon-like peptide-1, oxidative degradation products, spiroepoxides, enteroendocrine L cells, STC-1 cells, covalent protein binding, cysteine residues, prodrugs, oxidative activation, protein kinase C, ERK, CaM kinase II, anti-diabetic effects
MeSH terms
Animals, Anti-Inflammatory Agents, Non-Steroidal, Curcumin, Hypoglycemic Agents, Oxidation-Reduction, Cell Line, Tumor, Glucagon-Like Peptide 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review